159 related articles for article (PubMed ID: 26131374)
1. FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study.
Marin Dos Santos DH; Atallah ÁN
PeerJ; 2015; 3():e1015. PubMed ID: 26131374
[TBL] [Abstract][Full Text] [Related]
2. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
5. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
[TBL] [Abstract][Full Text] [Related]
6. Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA.
Swanson MJ; Johnston JL; Ross JS
Trials; 2021 Nov; 22(1):817. PubMed ID: 34789308
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
[TBL] [Abstract][Full Text] [Related]
8. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
[TBL] [Abstract][Full Text] [Related]
9. Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach.
Snider SH; Flume PA; Gentilin SL; Lesch WA; Sampson RR; Sonne SC
Contemp Clin Trials Commun; 2020 Jun; 18():100557. PubMed ID: 32258818
[TBL] [Abstract][Full Text] [Related]
10. Compliance with results reporting at ClinicalTrials.gov.
Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
[TBL] [Abstract][Full Text] [Related]
11. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
[TBL] [Abstract][Full Text] [Related]
12. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
Prayle AP; Hurley MN; Smyth AR
BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
[TBL] [Abstract][Full Text] [Related]
13. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA.
Talebi R; Redberg RF; Ross JS
Trials; 2020 Jul; 21(1):675. PubMed ID: 32703252
[TBL] [Abstract][Full Text] [Related]
14. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
Hirsch L
Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
[TBL] [Abstract][Full Text] [Related]
15. Reporting Compliance and Factors Influencing Timeliness of Stroke-Related Trial Results on ClinicalTrials.gov.
Cwajna M; Hamouda AM; Kendall N; Ghozy S; Elder BD; Kallmes DF
Transl Stroke Res; 2024 Jun; ():. PubMed ID: 38831158
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis.
Axson S; Mello MM; Lincow D; Yang C; Gross C; Ross JS; Miller J
BMJ Open; 2021 Jul; 11(7):e053248. PubMed ID: 34281933
[TBL] [Abstract][Full Text] [Related]
17. Evaluating publication bias for clinical trials supporting new dermatologic drug approvals from 2003 to 2018.
Ravichandran S; Mulligan KM; Ezaldein HH; Scott JF
Arch Dermatol Res; 2023 May; 315(4):831-838. PubMed ID: 36333459
[TBL] [Abstract][Full Text] [Related]
18. ClinicalTrials.gov reporting: strategies for success at an academic health center.
O'Reilly EK; Hassell NJ; Snyder DC; Natoli S; Liu I; Rimmler J; Amspacher V; Burnett BK; Parrish AB; Berglund JP; Stacy M
Clin Transl Sci; 2015 Feb; 8(1):48-51. PubMed ID: 25387802
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. E-cigarette manufacturers' compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs.
DeVito NJ; Drysdale H; McKee M; Goldacre B
Tob Control; 2023 Jan; 32(1):60-66. PubMed ID: 34127550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
